Your Location:
Home >
Browse articles >
Systematic Intervention Value of Tongxinluo Capsules in Clinical Cardiovascular Diseases Guided by Collateral Theory
Updated:2024-01-04
    • Systematic Intervention Value of Tongxinluo Capsules in Clinical Cardiovascular Diseases Guided by Collateral Theory

    • WU Xiang-jun , CHANG Cheng-cheng
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 24, Issue 8, Pages: 7-11(2018)
    • DOI: 10.13422/j.cnki.syfjx.20180892     

      CLC:

    Scan QR Code

  •  
  •  
  • Full Text(HTML)

  • Publication Info

  • Metrics

Sections
icon
The trial reading is over, you can activate your VIP account to continue reading.
Deactivate >
icon
The trial reading is over. You can log in to your account, go to the personal center, purchase VIP membership, and read the full text.
Already a VIP member?
Log in >

42

Views

80

Downloads

6

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Iron Homeostasis Imbalance Promotes Atherosclerosis and Therapeutic Mechanisms of Traditional Chinese Medicine
Analysis and Evaluation of Animal Models of Acute Myocardial Infarction Based on Clinical Characteristics in Chinese and Western Medicine
Mechanism of Huoxin Pills in Stabilizing Atherosclerotic Vulnerable Plaque Based on Network Pharmacology and Metabolomics
Differentiation and Treatment of Vulnerable Atherosclerotic Plaque Based on "Collateral Disease" Theory
Mechanism of Danlou Tablets in Ameliorating Hepatic Lipid Deposition by Regulating circCRIM1/miR-342-3p/SOX6-mediated Fatty Acid Synthesis

Related Author

WANG Maohong
XIONG Jianhua
ZHANG Hao
YAN Xiaohong
WAN Qiang
LIN Xuefeng
LIAN Kun
LI Weijun

Related Institution

Jiangxi University of Chinese Medicine
The Affiliated Hospital of Jiangxi University of Chinese Medicine
Hunan University of Chinese Medicine
School of Chinese Materia Medica,Guangzhou University of Chinese Medicine
Baiyunshan Pharmaceutical General Factory, Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd.